Related Experiment Videos

Ferro-mitogens: iron-containing compounds with lymphocyte-stimulatory properties

A Novogrodsky1, M Suthanthiran, K H Stenzel

  • 1Rogosin Institute, Cornell University Medical Center, New York, New York.

Cellular Immunology
|April 1, 1991
PubMed

Insights

Ferric ammonium citrate (FAC) acts as a T-cell mitogen with Interleukin-2 (IL-2), stimulating human peripheral blood mononuclear cells (PBM). This effect, potentiated by IL-2, involves iron-containing compounds and suggests a role for oxygen radicals.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Ferric ammonium citrate (FAC) is typically nonmitogenic for human peripheral blood mononuclear cells (PBM).
  • Interleukin-2 (IL-2) is crucial for T-cell proliferation and function.

Purpose of the Study:

  • To investigate the mitogenic potential of Ferric ammonium citrate (FAC) in combination with IL-2.
  • To explore the role of macrophages and signaling pathways in FAC-induced PBM stimulation.

Main Methods:

  • Culturing human peripheral blood mononuclear cells (PBM) with FAC and IL-2.
  • Assessing cell proliferation and receptor expression (IL-2, transferrin).
  • Investigating the effects of Concanavalin A (Con A) and inhibitors like thiourea and 3-amino-1,2,4-triazole.

Main Results:

  • FAC with IL-2 significantly increases PBM proliferation and expression of IL-2 and transferrin receptors.
  • FAC acts as a T-cell mitogen requiring macrophages and potentiates IL-2-induced TNF-alpha and IFN-gamma production.
  • Inhibitors suggest oxygen radicals or peroxidase mediate FAC-induced mitogenesis.

Conclusions:

  • Ferric ammonium citrate (FAC) is a potent ferro-mitogen for human PBM when combined with IL-2.
  • The mitogenic activity involves macrophage-dependent T-cell activation and cytokine production.
  • Oxygen radicals likely play a role in the signaling pathway of this ferro-mitogen class.

Related Concept Videos